Moving Towards Precision Therapy for Patients with AML: Clinical Challenges and Future Directions

In this clinic-focused program, review current and emerging strategies for personalizing AML treatment with expert-authored commentaries, and an on-demand Webcast capturing expert discussion from the 2018 hematologic malignancies symposium in San Diego. Then download the meeting slidesets and decision support resources on prognostic factors and key AML clinical trials to help guide your AML treatment recommendations.

Farhad Ravandi, MD
Eunice S. Wang, MD


New targeted agents are improving outcomes in newly diagnosed and relapsed/refractory AML. How can we optimize our diagnostic and treatment approaches for patients based on karyotype, FLT3 status, and other biomarkers?

Eunice S. Wang, MD Released: September 12, 2018

New drugs and drug combinations, particularly targeted therapies, are changing the treatment paradigm for patients with newly diagnosed and relapsed/refractory AML.

Farhad Ravandi, MD Released: October 15, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

This activity is supported by educational grants from
Boston Biomedical
Celgene Corporation
Daiichi Sankyo
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?